Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
Want to see XERS full AI Analyst Report?
Xeris Pharmaceuticals (XERS) Ownership Overview
5.43% Insiders
11.60% Mutual Funds
13.21% Other Institutional Investors
12.20% ETFs
57.56% Public Companies and
Individual Investors
The ownership structure of Xeris Pharmaceuticals (XERS) stock is a mix of institutional, retail, and individual investors. Approximately 37.00% of the company’s stock is owned by Institutional Investors, 5.43% is owned by Insiders, and 57.56% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 19, 2025 | xxxxxxxxxxxxx | $976234 | |
Aug 29, 2025 | xxxxxxxxxxxxx | $334477 | |
Aug 15, 2025 | xxxxxxxxxxxxx | $785825 | |
Aug 13, 2025 | xxxxxxxxxxxxx | $308975 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $157540 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $558018 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $5235892 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $1485305 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,379,579 | Institution | 4.85% | 52,456,165 | |
| 6,749,776 | Institution | 3.91% | 42,253,598 | |
| 6,560,144 | Institution | 3.80% | 41,066,501 | |
| 2,935,578 | Insider | 1.70% | 18,376,718 | |
| 2,379,184 | Institution | 1.38% | 14,893,692 | |
| 1,849,834 | Institution | 1.07% | 11,579,961 | |
| 1,802,725 | Insider | 1.04% | 11,285,059 | |
| 1,648,058 | Institution | 0.95% | 10,316,843 | |
| 1,408,940 | Insider | 0.82% | 8,819,964 | |
| 1,397,789 | Institution | 0.81% | 8,750,159 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,749,776 | Institution | 3.91% | 42,253,598 | |
| 2,379,184 | Institution | 1.38% | 14,893,692 | |
| 1,849,834 | Institution | 1.07% | 11,579,961 | |
| 1,648,058 | Institution | 0.95% | 10,316,843 | |
| 913,357 | Institution | 0.53% | 5,717,615 | |
| 598,140 | Institution | 0.35% | 3,744,356 | |
| 572,247 | Institution | 0.33% | 3,582,266 | |
| 490,423 | Institution | 0.28% | 3,070,048 | |
| 488,169 | Institution | 0.28% | 3,055,938 | |
| 484,655 | Institution | 0.28% | 3,033,940 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,952,056 | Institution | 2.87% | 28,721,925 | |
| 3,717,136 | Institution | 2.15% | 23,269,271 | |
| 1,855,362 | Institution | 1.07% | 10,761,100 | |
| 1,308,510 | Institution | 0.76% | 8,191,273 | |
| 1,082,793 | Institution | 0.63% | 6,648,349 | |
| 801,242 | Institution | 0.46% | 4,919,626 | |
| 783,019 | Institution | 0.45% | 4,541,510 | |
| 496,984 | Institution | 0.29% | 2,882,507 | |
| 439,886 | Institution | 0.25% | 2,700,900 | |
| 409,097 | Institution | 0.24% | 2,560,947 |
FAQ
Who Owns Xeris Pharmaceuticals (XERS)?
According to the latest TipRanks data, approximately 13.21% of the company's stock is held by institutional investors, 5.43% is held by insiders, and 57.56% is held by retail investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.21% of Xeris Pharmaceuticals (XERS) stock is held by institutional investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.56% of Xeris Pharmaceuticals (XERS) stock is held by retail investors.
Who owns the most shares of Xeris Pharmaceuticals (XERS)?
Vanguard owns the most shares of Xeris Pharmaceuticals (XERS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.